Madeleine Pharmaceuticals Pty. Ltd.

Status: Registered
Australian Company Number: 137514786
Australian Business Number: 14137514786
Registration date: Thu, 4th Jun 2009
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Madeleine Pharmaceuticals Pty Ltd is a limited by shares Australian proprietary company. Located at SA 5251 since 2009-06-04 the company is, as the updated on 2010-05-20 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2009-06-04. Known company numbers for Madeleine Pharmaceuticals Pty Ltd are as follows: ACN - 137514786, Australian Business Number - 14137514786. AUBiz found 2 trademarks that reference the abovementioned company. 2012-09-20 is the date the documents needed to start the registration process of trademark no 1513754 were submitted. This trademark is categorised as "word" and its application status is "registered, live". Other company trademarks include trademark number 1513755, application status "registered, live", registered on 2012-09-20 in the "word" category.

Details for ABN 14137514786

Type: Australian Private Company

ABN Status

Status From To
Active Thu, 4th Jun 2009 current

Main Name

Name From To
Madeleine Pharmaceuticals Pty. Ltd. Thu, 4th Jun 2009 current

Main Location

Location From To
SA 5251 Thu, 4th Jun 2009 current

Goods & Services Tax (GST)

Status From To
Registered Thu, 4th Jun 2009 current

Advertisements

Company Trademarks

Trademark number: 1513754

General information:
Application date: Thu, 20th Sep 2012
Lodgement date: Thu, 20th Sep 2012
Registered date: Thu, 20th Sep 2012
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: Fri, 4th Jan 2013
Sealing due date: Wed, 10th Jul 2013
Registered from date: Thu, 20th Sep 2012
Sealing date: Thu, 11th Jul 2013
Renewal due date: Tue, 20th Sep 2022
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: Yes
Lodgement type: AFS
Descriptive: Vestiras
Examination report number: 1
Examination class count: 1
NICE class code: 5
NICE occ number: 1
NICE description text: Pharmaceutical Preparations
Applicant information:
Suburb name: Mount Barker
Postcode: 5251
Australian state code: SA
Country code: AU
Attorney information:
Attorney code: 327341
Agency code: MA
Transaction type: Address for service of the trademark
Suburb name: Adelaide
Postcode: 5001
Australian state codee: SA
Attorney type: Attorney
Country code: AU

Trademark number: 1513755

General information:
Application date: Thu, 20th Sep 2012
Lodgement date: Thu, 20th Sep 2012
Registered date: Thu, 20th Sep 2012
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: Fri, 4th Jan 2013
Sealing due date: Wed, 10th Jul 2013
Registered from date: Thu, 20th Sep 2012
Sealing date: Thu, 11th Jul 2013
Renewal due date: Tue, 20th Sep 2022
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: Yes
Lodgement type: AFS
Descriptive: Vastiras
Examination report number: 1
Examination class count: 1
NICE class code: 5
NICE occ number: 1
NICE description text: Pharmaceutical Preparations
Applicant information:
Suburb name: Mount Barker
Postcode: 5251
Australian state code: SA
Country code: AU
Attorney information:
Attorney code: 327341
Agency code: MA
Transaction type: Address for service of the trademark
Suburb name: Adelaide
Postcode: 5001
Australian state codee: SA
Attorney type: Attorney
Country code: AU

Company Patents

Patent Application Number: 2011288919

General information:

Application date: Wed, 27th Mar 2013
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: NPE
Primary IPC mark: A61K 38/16
WIPO Application Number: WO2012/019237
Original WIPO Application Number: WO12/19237
PCT Application Number: PCT/AU2011/001026
Original PCT Application Number: PCT/AU11/01026
Accepted claims count: 17

International Patent Classification:

IPC Mark: A61M 5/14
Version date of the IPC Classification record: Sun, 1st Jan 2006
Section code: A - human necessities
Class code: 61 - medical or veterinary science; hygiene
Subclass code: M - devices for introducing media into, or onto, the body (introducing media into or onto the bodies of animals a61d0007000000; means for inserting tampons a61f0013260000; devices for administering food or medicines orally a61j; containers for collecting, storing or administering blood or medical fluids a61j0001050000); devices for transducing body media or for taking media from the body (surgery a61b; chemical aspects of surgical articles a61l; magnetotherapy using magnetic elements placed within the body a61n0002100000); devices for producing or ending sleep or stupor
Main group code: 5 - devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; accessories therefor, e.g. filling or cleaning devices, arm rests (tube connectors, tube couplings, valves or branch units, specially adapted for medical use a61m0039000000; containers specially adapted for medical or pharmaceutical purposes a61j0001000000)
Subgroup code: 14 - infusion devices, e.g. infusing by gravity; blood infusion; accessories therefor
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: Thu, 16th Feb 2012
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: Wed, 27th Mar 2013
Requested examination type: Request Full Examination
First report issue date: Fri, 14th Jun 2013
Further report issue date: Tue, 24th Sep 2013
Examination section: B3 Chemistry-Biology
Expiry date: Mon, 11th Aug 2031
Earliest priority date: Wed, 23rd Feb 2011
Acceptance Notice date: Thu, 31st Oct 2013
Sealing date: Thu, 13th Feb 2014
WIPO publication date: Thu, 16th Feb 2012
Effective patent date: Thu, 11th Aug 2011
Patent in force to: Tue, 11th Aug 2015

Patent Application Number: 2013234860

General information:

Application date: Fri, 26th Sep 2014
Patent status: Filed

The specification prior to acceptance and where the application has not lapsed

Patent type: NPE
Primary IPC mark: C12N 15/63
WIPO Application Number: WO2013/138850
Original WIPO Application Number: WO13/138850
PCT Application Number: PCT/AU2013/000273
Original PCT Application Number: PCT/AU13/00273

International Patent Classification:

IPC Mark: C12N 15/62
Version date of the IPC Classification record: Sun, 1st Jan 2006
Section code: C - chemistrymetallurgy
Class code: 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering
Subclass code: N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
Main group code: 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k)
Subgroup code: 62 - dna sequences coding for fusion proteins
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: Thu, 26th Sep 2013
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: Fri, 31st Oct 2014
Requested examination type: Request Full Examination
Examination status: Under Examination
First report issue date: Tue, 9th Dec 2014
Examination section: A2 Chemistry-Biotechnology
Expiry date: Sat, 19th Mar 2033
Earliest priority date: Mon, 19th Mar 2012
WIPO publication date: Thu, 26th Sep 2013
Effective patent date: Tue, 19th Mar 2013
Patent in force to: Sun, 19th Mar 2017

Patent Application Number: 2014100081

General information:

Application date: Thu, 30th Jan 2014
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: INNOVATION
Primary IPC mark: A61K 38/16

International Patent Classification:

IPC Mark: A61K 38/16
Version date of the IPC Classification record: Sun, 1st Jan 2006
Section code: A - human necessities
Class code: 61 - medical or veterinary science; hygiene
Subclass code: K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l)
Main group code: 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000)
Subgroup code: 16 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof
Mark type: First (ie Primary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: Thu, 30th Jan 2014
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Innovation
Expiry date: Sun, 11th Aug 2019
Earliest priority date: Wed, 23rd Feb 2011
Sealing date: Thu, 6th Feb 2014
Effective patent date: Thu, 11th Aug 2011
Continue renew fee paid date: Tue, 29th Jul 2014
Patent in force to: Tue, 11th Aug 2015

Find company

SA 5251 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.